...
首页> 外文期刊>Agriculture and Biology Journal of North America >Effect of co-administration of extracts of Vernonia amygdalina and Azadirachta indica on lipid profile and oxidative stress in hepatocytes of normal and diabetic rats
【24h】

Effect of co-administration of extracts of Vernonia amygdalina and Azadirachta indica on lipid profile and oxidative stress in hepatocytes of normal and diabetic rats

机译:扁桃和印and提取物的共同给药对正常和糖尿病大鼠肝细胞脂质分布和氧化应激的影响

获取原文
           

摘要

Effect of combined administration of extracts of Vernonia amydalina (VA) and Azadirachta indica (AI) on oxidative stress indices and serum lipid profile of normal and diabetic rats was evaluated. Result indicated a significant decrease (p0.05) in superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, and in the extent of lipid peroxidation non-significant increase (p>0.05) in malondialdehyde (MDA) concentration of untreated diabetic rats relative to the normal control. Treatment with combined extracts of VA and AI caused significant elevation in GPx, SOD and CAT activities, and reduction in MDA concentration in hepatocytes, hence antioxidant activity. This antioxidant potential was also demonstrated in normal rats which received the treatment. The combined extracts also caused mild increase and decrease in serum high density lipoprotein (HDL) cholesterol and triacylglycerol concentrations, but a respective significant (p<0.05) decrease and increase in serum total cholesterol (TC) and anti-atherogenic index (HDL/TC) when compared to diabetic control. Co-administration of extracts of VA and AI may positively modulate the antioxidant defense system and prevent atherosclerosis in diabetes.
机译:评估了Vernonia amydalina(VA)和Azadirachta indica(AI)提取物联合给药对正常和糖尿病大鼠的氧化应激指数和血清脂质谱的影响。结果表明未经治疗的糖尿病大鼠的超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)活性显着降低(p0.05),脂质过氧化程度显着增加(p> 0.05)相对于正常对照。用VA和AI的联合提取物处理可显着提高GPx,SOD和CAT活性,并降低肝细胞中MDA的浓度,从而降低抗氧化活性。在接受该治疗的正常大鼠中也证明了这种抗氧化剂的潜力。合并的提取物还引起血清高密度脂蛋白(HDL)胆固醇和三酰甘油浓度的轻度升高和降低,但血清总胆固醇(TC)和抗动脉粥样硬化指数(HDL / TC)分别显着(p <0.05)降低和升高)与糖尿病对照相比。 VA和AI提取物的共同给药可积极调节抗氧化防御系统并预防糖尿病的动脉粥样硬化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号